In Finland for 17 years from 1969 to 1985, 106 cases of tetanus were recorded, of which five children under the age of 18. Four children were fully vaccinated. Was the fifth vaccine vaccinated unknown? The last case of neonatal tetanus in Finland was registered in 1915, and vaccination was started in 1957.
One of the types of tetanus is tetanus of the newborns, it is almost not found in developed countries, its cause is infection of the baby through the umbilical cord, with non-sterile cutting. Instead of giving hygiene levels during delivery, bubbles of hydrogen peroxide, and teach them not to cut the umbilical cord with rusty scissors, WHO, of course, chose another strategy - universal vaccination of pregnant women in third world countries.Neonatal tetanus anti-immunization and protective antitoxin antibody. 1995, de Moraes-Pinto, J Infect Dis
Twenty babies entered a hospital in Nigeria with tetanus of newborns, and six mothers were vaccinated during pregnancy with at least two doses.All mothers and infants, including the unvaccinated, had antibody levels much higher than protective ones (0.07 and higher). Among the unvaccinated was 43% Mortality among vaccinated was 50%. However, [there is also a study proving that 2-3 inoculations during pregnancy significantly reduce the incidence of neonatal tetanus.Neonatal tetanus despite protective serum antitoxin concentration. 1991, Maselle, FEMS Microbiol Immunol.
Ten newborns with tetanus in Tanzania. The mothers of all but one were vaccinated during pregnancy, the level of antibodies in nine of them was above the "protective." The mother of the tenth was vaccinated two weeks before the birth. The mother of one of them received 14 vaccinations during her five pregnancies, the second received six in the last three years.In that infant, whose mother was never vaccinated, the level of antibodies was 100 and 400 times higher than the protective level. antibodies was three times higher than the protective level. The authors conclude, that there is no such thing as a "protective level of antibodies."